l-dopa

L-DOPA belongs to the category of dopamine precursors, serving as an orally active neurotransmitter metabolic precursor capable of crossing the blood-brain barrier and undergoing conversion to dopamine within the brain. The compound exhibits anti-hyperalgesic properties and finds application in Parkinson's disease research as well as in the induction of disease models.

L-DOPA methyl ester (LDME) is an agonist of dopamine D1 receptor.

[18F]-Labeled L-dopa precursor is used in the synthesis of 18F-labeled L-dopa[1].

L-Dopa precursor-1 (Compound 5a) is the precursor of 18F-L-Dopa. Serving as the core basis for a radiolabeling precursor, L-Dopa precursor-1 facilitates the introduction of non-metal radioactive elements through radiolabeling reactions. This compound can be utilized in studies related to renal denervation (RDN) surgery for refractory hypertension and chronic kidney disease.

DL-Dopa is a phenylalanine beta-hydroxylated derivative.

6-Hydroxy-L-DOPA is the 6-hydroxy derivative of the amino acid L-DOPA with neurotoxic properties. Exogenously administered 6-Hydroxy-L-DOPA is biotransformed by an amino acid decarboxylase to the highly potent and catecholamine-selective neurotoxin, 6-Hydroxydopamine.

DPBX-L-Dopa is a boron-containing dopa-derivative, acting as a bladder relaxant through non-catecholamine receptors.

3-O-methyl-L-DOPA is a metabolite of L-DOPA , produced by the activity of catechol O-methyltransferase. 3-O-methyl-L-DOPA may have effects of its own or it may compete with the actions of L-DOPA.

L-DOPA-D6 is the deuterium-labeled analog of L-DOPA. L-DOPA (T0848) (Levodopa) serves as an orally active metabolic precursor to the neurotransmitter dopamine. It is capable of crossing the blood-brain barrier and is subsequently converted into dopamine within the brain. L-DOPA (T0848) exhibits anti-hyperalgesic properties and holds potential for Parkinson's disease research.

L-DOPA-13C is the 13C labeled version of L-DOPA. L-DOPA (T0848) (Levodopa) is an orally active metabolic precursor of the neurotransmitter dopamine. It can cross the blood-brain barrier and is transformed into dopamine within the brain. L-DOPA (T0848) exhibits anti-nociceptive properties and holds potential for Parkinson's disease research.

L-DOPA-13C6 is L-DOPA (T0848) labeled with 13C. L-DOPA (Levodopa) serves as an orally active metabolic precursor to the neurotransmitter dopamine. It can cross the blood-brain barrier and is converted to dopamine in the brain. L-DOPA (T0848) exhibits anti-nociceptive effects and shows potential in Parkinson's disease research.

L-DOPA-2,5,6-D3 is a deuterated isotope of L-Dopa for isotope tracing. L-DOPA (T0848) is an orally active metabolic precursor of the neurotransmitter dopamine, capable of crossing the blood-brain barrier and converting to dopamine within the brain. It exhibits anti-hyperalgesic effects and is utilised in Parkinson's disease research.

L-DOPA (Standard) is a reference standard for research and analysis in studies involving L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of the neurotransmitter dopamine. It can cross the blood-brain barrier and be converted into dopamine in the brain. L-DOPA exhibits anti-hyperalgesic effects and holds potential in Parkinson’s disease research, and it can also be used to induce Parkinson’s disease models.

L-Dopa-2,5,6-d3 (Standard) is a reference standard of L-Dopa-2,5,6-d3 intended for quantitative analysis, quality control, and related biochemical research applications. L-DOPA-2,5,6-d3 is a deuterated isotope of L-Dopa for isotope tracing. L-DOPA is an orally active metabolic precursor of the neurotransmitter dopamine, capable of crossing the blood-brain barrier and converting to dopamine within the brain. It exhibits anti-hyperalgesic effects and is utilised in Parkinson's disease research.

L-Dopa-D6 (Standard) is a reference standard of L-Dopa-D6 intended for quantitative analysis, quality control, and related biochemical research applications. L-DOPA-d6 is the deuterium-labeled analog of L-DOPA. L-DOPA (Levodopa) serves as an orally active metabolic precursor to the neurotransmitter dopamine. It is capable of crossing the blood-brain barrier and is subsequently converted into dopamine within the brain. L-DOPA exhibits anti-hyperalgesic properties and holds potential for Parkinson's disease research.

L-3-O-Methyl-Dopa-[D3] H2O (Standard) is a reference standard of L-3-O-Methyl-Dopa-[D3] H2O intended for quantitative analysis, quality control, and related biochemical research applications.

L-Dopachrome is a nucleoside metabolite.

NMI 8739 (n-docosahexaenoyl dopamine) is an agonist of D2 autoreceptor. NMI 8739 reduces NO production and elicits concentration-dependent suppression of CCL-20, MCP-1 and IL-6 release.

PALDA (N-Palmitoyl dopamine) is a fatty acid dopamine found in the mammalian brain that is inactive against TRPV1 and inactivates at TRPV(1)R. It is used in the study of duodenal ulcers.

Methyldopa (MK-351), an alpha-adrenergic agonist (selective for α2-adrenergic receptors) psychoactive medicine, is served as an antihypertensive or sympatholytic.

Methyldopa hydrate (MK-351 hydrate) is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system, decreases production of dopamine, norepinephrine, and epinephrine, and exhibits NO-dependent sedative activity.

3-Methoxytyramine hydrochloride (3-O-methyl Dopamine hydrochloride) is an inactive metabolite of dopamine which can activate trace amine associated receptor 1 (TAAR1). 3-methoxytyramine can be found primarily in human brain and most tissues tissues; and in blood, cerebrospinal fluid (csf) or urine. Within a cell, 3-methoxytyramine is primarily located in the cytoplasm.

3-Methoxytyramine (3-O-methyl Dopamine) is a cellular metabolite of dopamine (3-hydroxytyramine), a neuromodulator that induces behavioral effects, induces significant ERK and CREB phosphorylation, and is capable of inducing a complex set of aberrant involuntary movements in acutely depleted dopamine-containing mice.

4-O-Methyldopamine hydrochloride ,with CAS No. 645-33-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-O-Methyldopamine hydrochloride provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.